| Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial MA Konstam, M Gheorghiade, JC Burnett, L Grinfeld, AP Maggioni, ... Jama 297 (12), 1319-1331, 2007 | 1842 | 2007 |
| Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review WD Weaver, RJ Simes, A Betriu, CL Grines, F Zijlstra, E Garcia, L Grinfeld, ... Jama 278 (23), 2093-2098, 1997 | 1670 | 1997 |
| Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial JR Teerlink, G Cotter, BA Davison, GM Felker, G Filippatos, ... The Lancet 381 (9860), 29-39, 2013 | 1037 | 2013 |
| Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST Clinical Status Trials M Gheorghiade, MA Konstam, JC Burnett, L Grinfeld, AP Maggioni, ... Jama 297 (12), 1332-1343, 2007 | 1014 | 2007 |
| Facilitated PCI in patients with ST-elevation myocardial infarction SG Ellis, M Tendera, MA de Belder, AJ van Boven, P Widimsky, ... New England Journal of Medicine 358 (21), 2205-2217, 2008 | 878 | 2008 |
| Clinical course and predictive value of congestion during hospitalization in patients admitted for worsening signs and symptoms of heart failure with reduced ejection fraction … AP Ambrosy, PS Pang, S Khan, MA Konstam, GC Fonarow, B Traver, ... European heart journal 34 (11), 835-843, 2013 | 524 | 2013 |
| Argentine randomized study: coronary angioplasty with stenting versus coronary bypass surgery in patients with multiple-vessel disease (ERACI II): 30-day and one-year follow-up … A Rodriguez, V Bernardi, J Navia, J Baldi, L Grinfeld, J Martinez, D Vogel, ... Journal of the American College of Cardiology 37 (1), 51-58, 2001 | 518 | 2001 |
| Effect of serelaxin on cardiac, renal, and hepatic biomarkers in the Relaxin in Acute Heart Failure (RELAX-AHF) development program: correlation with outcomes M Metra, G Cotter, BA Davison, GM Felker, G Filippatos, BH Greenberg, ... Journal of the American College of Cardiology 61 (2), 196-206, 2013 | 512 | 2013 |
| Clinical characteristics and outcome of patients with early (< 2h), intermediate (2–4h) and late (> 4h) presentation treated by primary coronary angioplasty or thrombolytic … F Zijlstra, A Patel, M Jones, CL Grines, S Ellis, E Garcia, L Grinfeld, ... European Heart Journal 23 (7), 550-557, 2002 | 334 | 2002 |
| Primary coronary angioplasty compared with intravenous thrombolytic therapy for acute myocardial infarction: six-month follow up and analysis of individual patient data from … P Collaborators Age (y) 50 (517), 1.0, 2003 | 317 | 2003 |
| Clinical implications of QRS duration in patients hospitalized with worsening heart failure and reduced left ventricular ejection fraction NC Wang, AP Maggioni, MA Konstam, F Zannad, HB Krasa, JC Burnett, ... Jama 299 (22), 2656-2666, 2008 | 243 | 2008 |
| Continental differences in clinical characteristics, management, and outcomes in patients hospitalized with worsening heart failure: results from the EVEREST (Efficacy of … JEA Blair, F Zannad, MA Konstam, T Cook, B Traver, JC Burnett, ... Journal of the American College of Cardiology 52 (20), 1640-1648, 2008 | 212 | 2008 |
| Rationale and design of the multicenter, randomized, double-blind, placebo-controlled study to evaluate the Efficacy of Vasopressin antagonism in Heart Failure: Outcome Study … M Gheorghiade, C Orlandi, JC Burnett Jr, D Demets, L Grinfeld, ... Journal of cardiac failure 11 (4), 260-269, 2005 | 212 | 2005 |
| Arterial perfusion cannula for extracorporeal circulation and other uses RR Grinfeld, LR Grinfeld US Patent 5,312,344, 1994 | 209 | 1994 |
| Clinical course of patients with hyponatremia and decompensated systolic heart failure and the effect of vasopressin receptor antagonism with tolvaptan PJ Hauptman, J Burnett, M Gheorghiade, L Grinfeld, MA Konstam, ... Journal of cardiac failure 19 (6), 390-397, 2013 | 185 | 2013 |
| Coronary stent thrombosis in the current drug-eluting stent era: insights from the ERACI III trial AE Rodriguez, J Mieres, C Fernandez-Pereira, CF Vigo, ... Journal of the American College of Cardiology 47 (1), 205-207, 2006 | 178 | 2006 |
| Sex‐based differences in bleeding and long term adverse events after percutaneous coronary intervention for acute myocardial infarction: three year results from the HORIZONS … J Yu, R Mehran, L Grinfeld, KE Xu, E Nikolsky, BR Brodie, B Witzenbichler, ... Catheterization and Cardiovascular Interventions 85 (3), 359-368, 2015 | 155 | 2015 |
| Changes in renal function during hospitalization and soon after discharge in patients admitted for worsening heart failure in the placebo group of the EVEREST trial JEA Blair, PS Pang, RW Schrier, M Metra, B Traver, T Cook, U Campia, ... European heart journal 32 (20), 2563-2572, 2011 | 155 | 2011 |
| Late loss of early benefit from drug-eluting stents when compared with bare-metal stents and coronary artery bypass surgery: 3 years follow-up of the ERACI III registry AE Rodriguez, AO Maree, J Mieres, D Berrocal, L Grinfeld, ... European heart journal 28 (17), 2118-2125, 2007 | 133 | 2007 |
| A comprehensive, longitudinal description of the in-hospital and post-discharge clinical, laboratory, and neurohormonal course of patients with heart failure who die or are re … M Gheorghiade, PS Pang, AP Ambrosy, G Lan, P Schmidt, G Filippatos, ... Heart failure reviews 17, 485-509, 2012 | 131 | 2012 |
